Company intelligence / Profile preview

Calibar Pharmaceuticals

Santa Barbara, California, United States

Ownership: Private
Development stage: Other

Overview

Calibar Pharmaceuticals is developing a proprietary oral delivery platform specifically designed for biologics and peptides that are typically administered via injection. Their lead programs focus on the oral delivery of GLP-1 receptor agonists and insulin for metabolic disorders.

Therapeutic areas: Endocrinology
Modalities: PeptidesHydrogel-based drug delivery therapy
Industry: Biotech

Beyond the preview

Go deeper on Calibar Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Calibar Pharmaceuticals.

Explore the full profile